Koers Helius Medical Technologies, Inc. Toronto S.E.
Aandelen
HSM
US42328V6039
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 977K 1,33 mln. 910K | Omzet 2025 * | 5,72 mln. 7,81 mln. 5,33 mln. | Marktkapitalisatie | 7,15 mln. 9,78 mln. 6,67 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -11 mln. -15,03 mln. -10,25 mln. | Nettowinst (verlies) 2025 * | -9 mln. -12,3 mln. -8,39 mln. | EV/omzet 2024 * | 7,32 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,25 x |
K/w-verhouding 2024 * |
-0,25
x | K/w-verhouding 2025 * |
-0,6
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,15% |
Recentste transcriptie over Helius Medical Technologies, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dane Andreeff
CEO | Chief Executive Officer | 58 | 04-08-17 |
Director of Finance/CFO | 63 | 09-06-20 | |
Chief Tech/Sci/R&D Officer | 57 | 08-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward Straw
BRD | Director/Board Member | 85 | 18-11-14 |
Dane Andreeff
CEO | Chief Executive Officer | 58 | 04-08-17 |
Blane Walter
CHM | Chairman | 53 | 29-12-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,62% | 219 mld. | |
+6,70% | 183 mld. | |
+11,94% | 132 mld. | |
+24,60% | 106 mld. | |
-2,66% | 62,09 mld. | |
+4,81% | 50,88 mld. | |
+11,55% | 50,8 mld. | |
-1,09% | 40,64 mld. | |
+26,82% | 31,59 mld. |